Catalent, Inc. (NYSE:CTLT) (“Catalent”), the leading global provider of
advanced delivery technologies and development solutions for drugs,
biologics, and consumer health products, today announced that it will
release financial results for the fourth quarter and fiscal year ended
June 30, 2015 after the market close on Wednesday, September 2, 2015.
The Company’s management will host a webcast to discuss the results at
4:30 p.m. ET on the same day.
Catalent invites all interested parties to listen to the webcast, which
will be accessible through Catalent’s website at http://investor.catalent.com.
A supplemental slide presentation will also be available in the
“Investors” section of Catalent’s website prior to the start of the
webcast.
The webcast replay, along with the supplemental slides, will be
available for 90 days in the “Investors” section at www.catalent.com.
About Catalent, Inc.
Catalent, Inc. (NYSE: CTLT) is the leading global provider of advanced
delivery technologies and development solutions for drugs, biologics and
consumer health products. With over 80 years serving the industry,
Catalent has proven expertise in bringing more customer products to
market faster, enhancing product performance and ensuring reliable
clinical and commercial product supply. Catalent employs approximately
8,600 people, including over 1,000 scientists, at 30 facilities across 5
continents and in fiscal 2014 generated more than $1.8 billion in annual
revenue. Catalent is headquartered in Somerset, N.J. For more
information, please visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
Investors:
Thomas Castellano, Catalent, Inc.
Jeremy Feffer, Bertner Advisors, LLC
732-537-6325
investors@catalent.com